Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jaffe

Showing results (521-530 of 579) with videos related to

Pageof 58
Sort By:
The Lancet. Neurology|February 24, 2017
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Laura Balcer, Steven Galetta, et al.
Investigative Ophthalmology & Visual Science|August 12, 2017
Fundus Autofluorescence Findings in Eyes With Birdshot ChorioretinitisChristian Böni, Jennifer E Thorne, Richard F Spaide, et al.
Ophthalmology|February 19, 2018
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Wei Pan, Gui-Shuang Ying, et al.
Ophthalmology Science|January 26, 2026
Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular DegenerationUsha Chakravarthy, Lajos Csincsik, Kelvin Y C Teo, et al.
Ophthalmology and Therapy|June 9, 2023
Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIERRamin Tadayoni, Glenn J Jaffe, Frank G Holz, et al.
Biological Psychiatry|November 19, 2013
Brain potentials measured during a Go/NoGo task predict completion of substance abuse treatmentVaughn R Steele, Brandi C Fink, J Michael Maurer, et al.
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
The British Journal of Ophthalmology|July 24, 2021
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWKYuichiro Ogura, Glenn J Jaffe, Chui Ming Gemmy Cheung, et al.
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Pageof 58

Showing results (521-530 of 579) with videos related to

Sort By:
Pageof 58
The Lancet. Neurology|February 24, 2017
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Laura Balcer, Steven Galetta, et al.
Investigative Ophthalmology & Visual Science|August 12, 2017
Fundus Autofluorescence Findings in Eyes With Birdshot ChorioretinitisChristian Böni, Jennifer E Thorne, Richard F Spaide, et al.
Ophthalmology|February 19, 2018
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Wei Pan, Gui-Shuang Ying, et al.
Ophthalmology Science|January 26, 2026
Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular DegenerationUsha Chakravarthy, Lajos Csincsik, Kelvin Y C Teo, et al.
Ophthalmology and Therapy|June 9, 2023
Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIERRamin Tadayoni, Glenn J Jaffe, Frank G Holz, et al.
Biological Psychiatry|November 19, 2013
Brain potentials measured during a Go/NoGo task predict completion of substance abuse treatmentVaughn R Steele, Brandi C Fink, J Michael Maurer, et al.
Ophthalmology. Retina|April 25, 2019
Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATTCynthia A Toth, Vincent Tai, Maxwell Pistilli, et al.
The British Journal of Ophthalmology|July 24, 2021
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWKYuichiro Ogura, Glenn J Jaffe, Chui Ming Gemmy Cheung, et al.
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Pageof 58